Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Volatility: 40.88% (As of Jun. 28, 2026)


ROCO:4186 Taiwan Advance Bio-Pharmaceutical Inc ROCO:4186
52 GF Score
Price NT$9.86
GF Value NT$17.86
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Taiwan Advance Bio-Pharmaceutical Volatility?

Taiwan Advance Bio-Pharmaceutical ROCO:4186 -3.80% 52 Volatility is 40.88% as of Jun. 28, 2026. GuruFocus rates ROCO:4186 with a GF Score™ of 52/100 and a GF Value™ of NT$17.86 (Possible Value Trap). The stock has 4 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-06-28), Taiwan Advance Bio-Pharmaceutical's Volatility is 40.88%.


Taiwan Advance Bio-Pharmaceutical  (ROCO:4186) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Taiwan Advance Bio-Pharmaceutical Volatility Related Terms


ROCO:4186 vs VRTX, REGN, ALNY: Volatility Comparison

For the Biotechnology subindustry, Taiwan Advance Bio-Pharmaceutical's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Advance Bio-Pharmaceutical Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Advance Bio-Pharmaceutical's Volatility distribution charts can be found below:

* The bar in red indicates where Taiwan Advance Bio-Pharmaceutical's Volatility falls into.


ROCO:4186
52GF Score
Taiwan Advance Bio-Pharmaceutical Inc ROCO:4186
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiwan Advance Bio-Pharmaceutical  (ROCO:4186) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 40.88% mean?
Taiwan Advance Bio-Pharmaceutical (ROCO:4186) has a Volatility of 40.88% as of Jun. 28, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Taiwan Advance Bio-Pharmaceutical and its competitors.
Is Taiwan Advance Bio-Pharmaceutical's Volatility too high?
Taiwan Advance Bio-Pharmaceutical's current Volatility is 40.88%. Overall, Taiwan Advance Bio-Pharmaceutical has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Taiwan Advance Bio-Pharmaceutical's Volatility compare to VRTX and REGN?
Taiwan Advance Bio-Pharmaceutical's Volatility of 40.88% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Taiwan Advance Bio-Pharmaceutical and its competitors. Taiwan Advance Bio-Pharmaceutical's current Volatility is 40.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiwan Advance Bio-Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Taiwan Advance Bio-Pharmaceutical (ROCO:4186) is currently considered Possible Value Trap. The stock's GF Value™ is NT$17.86, compared to a current price of NT$9.86 — trading 44.8% below its estimated fair value. The current Volatility is 40.88%. Taiwan Advance Bio-Pharmaceutical's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Taiwan Advance Bio-Pharmaceutical (ROCO:4186), the current Volatility is 40.88% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Overvalued in 2026?

Based on GuruFocus' analysis, Taiwan Advance Bio-Pharmaceutical stock appears to be undervalued. The current stock price of NT$9.86 is trading 44.8% below its estimated GF Value™ of NT$17.86. GuruFocus considers Taiwan Advance Bio-Pharmaceutical to be Possible Value Trap.

Key valuation signals for ROCO:4186:

  • Volatility: 40.88%
  • GF Value™: NT$17.86 vs. price of NT$9.86 (44.8% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4186 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Taiwan Advance Bio-Pharmaceutical Business Description

Address No. 363, Section 2, Fuxing South Road, 5th Floor, Daan District, New Taipei City, TWN, 22180
Taiwan Advance Bio-Pharmaceutical Inc operates in the food safety industry. The company's products include a Food safety test kit, Animal test kit, Pesticide test kit, Mycotoxin test kit, Nuleic acid extraction kit.
52GF Score

Get the complete analysis for ROCO:4186

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$9.86
Price
NT$17.86
GF Value